245 related articles for article (PubMed ID: 28739841)
1. The 'Goldilocks zone' of fatty acid metabolism; to ensure that the relationship with cardiac function is just right.
Kerr M; Dodd MS; Heather LC
Clin Sci (Lond); 2017 Aug; 131(16):2079-2094. PubMed ID: 28739841
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid oxidation in the heart.
Grynberg A; Demaison L
J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S11-7. PubMed ID: 8891866
[TBL] [Abstract][Full Text] [Related]
3. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
4. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
5. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
[TBL] [Abstract][Full Text] [Related]
6. Energetic myocardial metabolism and oxidative stress: let's make them our friends in the fight against heart failure.
Scolletta S; Biagioli B
Biomed Pharmacother; 2010 Mar; 64(3):203-7. PubMed ID: 19954925
[TBL] [Abstract][Full Text] [Related]
7. Activating PPARα prevents post-ischemic contractile dysfunction in hypertrophied neonatal hearts.
Lam VH; Zhang L; Huqi A; Fukushima A; Tanner BA; Onay-Besikci A; Keung W; Kantor PF; Jaswal JS; Rebeyka IM; Lopaschuk GD
Circ Res; 2015 Jun; 117(1):41-51. PubMed ID: 25977309
[TBL] [Abstract][Full Text] [Related]
8. [Modifications in myocardial energy metabolism in diabetic patients]].
Grynberg A
Diabetes Metab; 2001 Nov; 27(5 Pt 2):S12-9. PubMed ID: 11910980
[TBL] [Abstract][Full Text] [Related]
9. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes.
Fukushima A; Lopaschuk GD
Biochim Biophys Acta; 2016 Oct; 1861(10):1525-34. PubMed ID: 26996746
[TBL] [Abstract][Full Text] [Related]
10. Myocardial fatty acid uptake through CD36 is indispensable for sufficient bioenergetic metabolism to prevent progression of pressure overload-induced heart failure.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Obinata H; Yamaguchi A; Hanaoka H; Hishiki T; Hayakawa N; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Sci Rep; 2018 Aug; 8(1):12035. PubMed ID: 30104639
[TBL] [Abstract][Full Text] [Related]
11. Metabolic remodelling of the failing heart: beneficial or detrimental?
van Bilsen M; van Nieuwenhoven FA; van der Vusse GJ
Cardiovasc Res; 2009 Feb; 81(3):420-8. PubMed ID: 18854380
[TBL] [Abstract][Full Text] [Related]
12. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
13. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
14. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
15. Robust suppression of cardiac energy catabolism with marked accumulation of energy substrates during lipopolysaccharide-induced cardiac dysfunction in mice.
Umbarawan Y; Syamsunarno MRAA; Obinata H; Yamaguchi A; Sunaga H; Matsui H; Hishiki T; Matsuura T; Koitabashi N; Obokata M; Hanaoka H; Haque A; Kunimoto F; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Metabolism; 2017 Dec; 77():47-57. PubMed ID: 28941596
[TBL] [Abstract][Full Text] [Related]
16. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
Visser FC
Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
[TBL] [Abstract][Full Text] [Related]
17. Regulation of sarcolemmal transport of substrates in the healthy and diseased heart.
Glatz JF; Bonen A; Ouwens DM; Luiken JJ
Cardiovasc Drugs Ther; 2006 Dec; 20(6):471-6. PubMed ID: 17119873
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical role of lipid metabolism in heart function and dysfunction.
Dhalla NS; Elimban V; Rupp H
Mol Cell Biochem; 1992 Oct; 116(1-2):3-9. PubMed ID: 1480151
[TBL] [Abstract][Full Text] [Related]
19. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle.
Zhang L; Keung W; Samokhvalov V; Wang W; Lopaschuk GD
Biochim Biophys Acta; 2010 Jan; 1801(1):1-22. PubMed ID: 19782765
[TBL] [Abstract][Full Text] [Related]
20. The heart is better protected against myocardial infarction in the fed state compared to the fasted state.
Liepinsh E; Makrecka M; Kuka J; Makarova E; Vilskersts R; Cirule H; Sevostjanovs E; Grinberga S; Pugovics O; Dambrova M
Metabolism; 2014 Jan; 63(1):127-36. PubMed ID: 24140100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
